DRUG · Unmapped registry intervention
AMG 691
Find medicine records ·
Find other trials using this name
Clinical trial
A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and Participants With Mild-to-Moderate Asthma
NCT06637371
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Placebo
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedA Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and Participants With Mild-to-Moderate Asthma
Design: INTERVENTIONAL · Status: ACTIVE NOT RECRUITING · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Asthmaverified · MONDO: asthma
Interventions
Sponsors & collaborators
Amgenlead sponsor
Mapped research locations
BostonMassachusetts, United States1San AntonioTexas, United States1LondonUnited Kingdom1Oklahoma CityOklahoma, United States1RochesterMinnesota, United States1Chapel HillNorth Carolina, United States1ManchesterUnited Kingdom1RaleighNorth Carolina, United States1Saint PaulMinnesota, United States1CambridgeUnited Kingdom1ColumbusGeorgia, United States1AdelaideSouth Australia, Australia1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06637371 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.